Pharmathen S.A.: Clinical Trials

2 trials sponsored by Pharmathen S.A., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 11Completed 1

Follow Pharmathen S.A.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study to Evaluate the Bioavailability Between Two Products Containing Paliperidone 100 mg in the Form of a Prolonged Release Suspension for Injection in Patients With Schizophrenia Who Are Already Stabilized in This Treatment
Paliperidone - Schizophrenia
Phase 1 / Phase 2CompletedPharmathen S.A.702018-03-112019-07-19
Technical Performance Assessment of Tc-99m Tetrofosmin for Differentiation of Recurrence vs Radiation Necrosis in Patients With Glioma
Tc-99M-Tetrofosmin SPECT, F-18 FDG PET - Glioma (Diagnosis)
Phase 2CompletedProactina S.A.322016-09-012018-01-26

Conditions studied

Disease (1)  ·  Glioma (1)  ·  Schizophrenia (1)

Interventions

Paliperidone Palmitate (1)

Countries

France (1)  ·  Hungary (1)  ·  Jordan (1)

Top investigators

Lina Sabbah (1)